Skip to main content
. 2018 May 16;2018:3086586. doi: 10.1155/2018/3086586

Table 2.

In vitro antifungal susceptibility of eight antifungal agents against 134 Candida spp. isolated from Candida-associated denture stomatitis.

Candida species/number of strains/antifungal drugs MIC µg/mL
MIC range MIC50 MIC90 GM
All Candida species (134)
 FLC 0.016–16 0.125 8 0.26
 ITC 0.016–16 0.064 0.5 0.08
 VRC 0.016–4 0.125 0.5 0.11
 AMB 0.016–2 0.064 0.25 0.05
 CAS 0.008–2 0.125 0.5 0.12
 TRB 2–≥128 128 >128 65.00
 POS 0.032–0.5 0.016 0.125 0.03
 KET 0.016–4 0.125 1 0.15
C. albicans (84)
 FLC 0.016–16 0.064 2 0.09
 ITC 0.016–0.5 0.032 0.5 0.04
 VRC 0.032–0.25 0.064 0.25 0.08
 AMB 0.008–0.25 0.032 0.25 0.03
 CAS 0.008–1 0.064 0.5 0.08
 TRB 2–≥128 128 128 96.68
 POS 0.032–0.5 0.016 0.032 0.01
 KET 0.016–2 0.125 1 0.09
C. glabrata (23)
 FLC 0.25–≥16 4 64 5.24
 ITC 0.125–0.5 0.25 0.5 0.26
 VRC 0.125–2 0.25 0.5 0.24
 AMB 0.032–0.5 0.032 0.5 0.07
 CAS 0.008–2 0.5 1 0.51
 TRB 8–>128 16 64 19.77
 POS 0.125–0.5 0.125 0.5 0.19
 KET 0.064–1 0.125 0.5 0.14
C. tropicalis (16)
 FLC 0.125–≥16 0.125 4 0.42
 ITC 0.016–16 0.016 4 0.27
 VRC 0.016–4 0.032 2 0.08
 AMB 0.016–2 0.125 1 0.17
 CAS 0.008–1 0.032 0.125 0.05
 TRB 4–≥128 64 128 53.81
 POS 0.016–0.25 0.032 0.25 0.05
 KET 0.032–4 0.25 2 0.23
C. parapsilosis (11)
 FLC 0.25–4 0.25 2 0.46
 ITC 0.125–8 0.25 4 0.46
 VRC 0.25–2 0.25 1 0.41
 AMB 0.016–2 0.25 1 0.19
 CAS 0.008–2 0.25 1 0.41
 TRB 4–≥128 128 128 49.74
 POS 0.032–0.125 0.032 0.125 0.05
 KET 0.125–2 0.125 1 0.25

FLC, fluconazole; ITC, itraconazole; VRC, voriconazole; AMB, amphotericin B; CAS, caspofungin; TRB, terbinafine; POS, posaconazole; KET, ketoconazole; GM, geometric mean; MIC, minimum inhibition concentration; MIC50 and MIC90, concentration at which 50% and 90% of the strains were inhibited, respectively.